Zhendong Zheng

机构：University of Science and Technology of China, Suzhou University of Science and Technology, General Hospital of Shenyang Military Region, Liaoning Cancer Hospital & Institute, China Medical University · ORCID：0000-0002-6486-3062

发表论文 37 篇 · 总被引 184 次 · h-index 8

代表论文

• Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial (2025 · Signal Transduction and Targeted Therapy · 被引 20)
• Mitigating citrus fruit cracking: the efficacy of chelated calcium or silicon foliar fertilizers in ‘Okitsu no. 58’ citrus fruit (2024 · Frontiers in Plant Science · 被引 13)
• Effects of Exogenous Application of Glycine Betaine Treatment on ‘Huangguoggan’ Fruit during Postharvest Storage (2023 · International Journal of Molecular Sciences · 被引 13)
• UbiMoE: A Ubiquitous Mixture-of-Experts Vision Transformer Accelerator With Hybrid Computation Pattern on FPGA (2025 · 被引 8)
• First-line treatment of anti-EGFR monoclonal antibody cetuximab β plus FOLFIRI versus FOLFIRI alone in Chinese patients with RAS/BRAF wild-type metastatic colorectal cancer: a randomized, phase 3 trial (2025 · Signal Transduction and Targeted Therapy · 被引 8)
• Effect of Natural Variation and Rootstock on Fruit Quality and Volatile Organic Compounds of ‘Kiyomi tangor’ (Citrus reticulata Blanco) Citrus (2023 · International Journal of Molecular Sciences · 被引 8)